No Data
No Data
Individual stock information.
Fandeli <3137.T> is at a stop-high buy alert. On December 30, after the market closes, the introduction of a shareholder incentive program was announced. Every year at the end of March, shareholders holding more than 100 shares will receive meal coupons applicable to the company's domestic high-brand frozen food "旬をすぐに" according to the number of shares held. SoleiZia <4597.T> rebounded. The earnings forecast for the fiscal year ending December 2024 has been revised, with the consolidated operating loss adjusted from the previous 1.15 billion yen to 1.05 billion yen (the previous period was 1.13 billion yen).
Solasia Pharma KK: Notice regarding revisions to the 2024 full-year earnings forecast
Solasia Pharma Slashes Earnings Forecast for 2024 Due to Sluggish Shipments, Delayed Out-licensing
Emerging Markets stocks digest: DWTI surged, Headwater briefly hit the daily limit up.
＜4576＞ DWTI 201 +38 surged sharply. It announced that it received notification from Kowa, the licensee, that the glaucoma and ocular hypertension treatment "Graa Alpha Combination Eye Drops (domestic product name)" has been approved in Thailand for the Rho kinase inhibitor Ripasudil hydrochloride hydrate it developed, which is viewed favorably. The product has been on the domestic market since December 2022 through Kowa, and discussions were held regarding overseas sales. This is the first time the product has obtained approval overseas, and Kowa will continue to.
Hot Stocks Digest (Morning Session): WNI Weather, Marumae, Headwater, ETC.
Sumitomo Electric Industries <5802>: 2845 yen (-39.5 yen) fell back. It has been reported that they will abandon plans for mass production of semiconductor materials for electric vehicles. In addition to constructing a new factory in Toyama Prefecture, there were plans to establish a new line at an existing factory in Hyogo Prefecture, but it seems that these plans are being retracted due to the uncertain recovery of EV demand. The total investment amount was expected to be 30 billion yen. They were set to receive up to 10 billion yen in subsidies from the Ministry of Economy, Trade and Industry for the factory construction, but this has also been canceled. This is due to a change in the long-term Global Strategy.
Solexia - Significant decline, discontent with the downward revision of the full-year Financial Estimates for the fiscal year ending December 2024.
A significant drop. After the close of trading on the 27th, it was announced that the financial estimates for the fiscal year ending December 2024 were revised downward, leading to an initial sell-off. Revenue is revised down by 1.09 billion yen from the previous estimated value (lower limit) to 0.16 billion yen. The sales partner had anticipated completing the shipment of inventory around mid-year, but in reality, shipments Stunk, resulting in low shipment volume of new facility manufactured products this year. Additionally, the anticipated rights derivation of Darubias in China that was part of the previous financial estimates has not materialized.